BioCentury | Sep 17, 2020
Deals

Awaiting dialogue with FDA on GI program, microbiome play Finch looks to autism, HBV with new $90M round

...were Baupost Group, Humboldt Fund, MSD Capital, MSD Partners...
BioCentury | Mar 18, 2020
Finance

March 17 Quick Takes: Tempus, Circle, Immatics, Exuma, CFIUS

...Biotech Corp. and raised $19 million in a series B round that includes investments by MSD Partners...
BioCentury | Nov 16, 2018
Financial News

Ziopharm raises $50M in private placement

...and a five-year warrant to purchase one share at $3.01. The placement was led by MSD Partners...
Items per page:
1 - 3 of 3
BioCentury | Sep 17, 2020
Deals

Awaiting dialogue with FDA on GI program, microbiome play Finch looks to autism, HBV with new $90M round

...were Baupost Group, Humboldt Fund, MSD Capital, MSD Partners...
BioCentury | Mar 18, 2020
Finance

March 17 Quick Takes: Tempus, Circle, Immatics, Exuma, CFIUS

...Biotech Corp. and raised $19 million in a series B round that includes investments by MSD Partners...
BioCentury | Nov 16, 2018
Financial News

Ziopharm raises $50M in private placement

...and a five-year warrant to purchase one share at $3.01. The placement was led by MSD Partners...
Items per page:
1 - 3 of 3